Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01169324 · ClinicalTrials.gov registry record · NA

Effect of Deep Brain Stimulation (DBS) on Sleep Architecture in Patients With Movement Disorders

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
17
Enrollment target

NCT01169324 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 17 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01169324, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
17 participants
Enrollment target

Study Summary

The purpose of this prospective, participant-blinded trial is to determine the changes in sleep architecture in a cohort of subjects who have undergone deep brain stimulation (DBS) surgery for treatment of movement disorders such as moderate to advanced Parkinson's disease (PD), tremor, or dystonia. Our preliminary observational data suggest that unilateral subthalamic nucleus (STN) DBS improves subjective sleep quality in PD patients 6 months after the procedure. The cause of this improvement in sleep quality is unknown, and this study proposes the use of polysomnography (PSG) to test whether the improvement in sleep is independent of improvement in night-time mobility associated with DBS treatment of the motor symptoms of PD, tremor, or dystonia.

Interventions

  • OTHER Alteration of DBS stimulator settings

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2010-07-15
Est. Completion 2015-12-11
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT01169324

The ClinicalTrials.gov registry entry for NCT01169324 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Alteration of DBS stimulator settings is the first listed.

NCT01169324 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01169324 about?

NCT01169324 is a clinical study titled "Effect of Deep Brain Stimulation (DBS) on Sleep Architecture in Patients With Movement Disorders". The purpose of this prospective, participant-blinded trial is to determine the changes in sleep architecture in a cohort of subjects who have undergone deep brain stimulation (DBS) surgery for treatment of movement disorders such as moderate to advanced Parkinson's disease (PD), tremor, or dystonia....

What is the current status of trial NCT01169324?

This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2010-07-15. Estimated completion is 2015-12-11.

What interventions are being tested in trial NCT01169324?

The interventions under investigation include: Alteration of DBS stimulator settings (OTHER).

Who is sponsoring clinical trial NCT01169324?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.